Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Practical Laboratory Use of Angiotensin II (Asp-Arg-Val-Tyr-

    2026-05-27

    Practical Laboratory Use of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe)

    What This Product Solves

    Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe, CAS 4474-91-3) is a synthetic form of the endogenous octapeptide hormone widely implemented in experimental systems to probe cardiovascular physiology and disease mechanisms. Its principal laboratory applications include:

    • Inducing vasoconstriction and investigating hypertension mechanisms through targeted activation of G protein-coupled receptors (GPCRs) on vascular smooth muscle cells.
    • Modeling and dissecting cardiovascular remodeling, particularly in the context of vascular smooth muscle cell hypertrophy research and abdominal aortic aneurysm models.
    • Stimulating aldosterone secretion and downstream renal sodium/water reabsorption for studies of fluid balance regulation.

    As a potent vasopressor and Angiotensin II receptor agonist, Angiotensin II enables controlled, reproducible perturbation of signaling cascades relevant to cardiovascular remodeling investigation. It is a tool of choice for researchers requiring precise modulation of blood pressure or vascular tone in vitro and in vivo, as detailed in the product information.

    This article complements the foundational workflow and troubleshooting advice in Practical Guidance for Angiotensin II (A1042) Research Use, and expands on mechanistic and translational considerations discussed in Angiotensin II: Mechanistic Insights and Translational Study.

    Protocol Parameters

    • Stock solution preparation | ≥10 mM in sterile water | Suitable for all standard in vitro and in vivo setups | Ensures high solubility and stability for aliquoting and storage; do not use ethanol due to insolubility | product dossier
    • Cell culture treatment | 100 nM for 4 hours | For stimulation of NADH and NADPH oxidase activity in vascular smooth muscle cell hypertrophy research | Matches common laboratory induction of acute signaling pathways and hypertrophic responses | product dossier
    • Animal model administration | 500–1000 ng/min/kg via subcutaneous minipump, up to 28 days | Used in hypertension mechanism study and abdominal aortic aneurysm model induction | Achieves reproducible elevation of blood pressure and vascular remodeling in rodents | product dossier
    • Receptor binding assay | IC50 1–10 nM | For benchmarking receptor agonism and comparing GPCR engagement | Aligns with reported affinity ranges for robust Angiotensin II receptor activation | product dossier
    • Solution storage | Aliquots at -80°C (short-term), desiccated at -20°C (powder) | For maintaining peptide integrity and preventing degradation | Prolongs usability of working stocks; long-term solution storage is not recommended | product dossier

    Workflow Setup and QC Checklist

    1. Reconstitution: Dissolve Angiotensin II at concentrations above 10 mM in sterile water. Confirm complete dissolution visually; avoid using ethanol as the peptide is insoluble.
    2. Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles. Use low-protein binding tubes to reduce peptide loss.
    3. Storage: Store lyophilized powder desiccated at -20°C. Store stock solutions at -80°C for up to several months. Discard unused solutions after thawing if not used immediately.
    4. Experimental controls: Include vehicle controls (sterile water) in both cell and animal studies to distinguish peptide-specific effects.
    5. Dosing validation: For in vivo studies, verify minipump delivery rate and confirm dosing calculations are weight-adjusted for each subject.
    6. Documentation: Record lot number, reconstitution date, and storage conditions for reproducibility.

    Common Failure Modes and Fixes

    • Incomplete dissolution: If visible particulates remain, gently vortex and briefly sonicate. Confirm water temperature does not exceed room temperature to avoid peptide degradation.
    • Reduced activity in cell assays: Check aliquot storage history; avoid repeated freeze-thaw cycles. Prepare fresh stocks if activity loss is suspected.
    • Precipitation in injection systems: Ensure all tubing and reservoirs are pre-rinsed with sterile water. Re-filter peptide solution (0.22 μm) prior to animal administration if necessary.
    • Unexpected responses in animal models: Verify minipump function and dosing accuracy. Confirm that the peptide has not exceeded its recommended storage duration.
    • Batch-to-batch variability: Standardize preparation protocols and include internal positive controls for each experimental series.

    Scope and Limitations

    Angiotensin II is validated for use as a research reagent in vascular smooth muscle cell hypertrophy research, hypertension mechanism study, and cardiovascular remodeling investigation. It is not intended for diagnostic, therapeutic, or clinical use. The product is not suitable for long-term solution storage—freshly prepared aliquots are recommended for each experiment. Usage outside the specified solubility and storage conditions (e.g., in ethanol or at elevated temperatures) can compromise peptide integrity and reproducibility. Researchers should restrict application to controlled, mechanistic studies as outlined in the product information.

    Conclusion

    Angiotensin II (A1042) provides a reliable, dossier-backed tool for dissecting GPCR-mediated signaling, vascular remodeling, and hypertensive processes in preclinical models. Adhering to best practices for solution preparation, storage, and experimental design is essential for consistent and interpretable results. For further mechanistic context and advanced study design considerations, see the referenced internal articles. For complete technical specifications or to order, consult the APExBIO Angiotensin II product page.